MEI Pharma, Inc. (MEIP)

[wiredawg]

Well, I can't give any specifics, but everything I've come across gives some general costs...take it for what's it worth. But, this seems to be a crutch of all bio-pharms...of course there a few exceptions 2 that come to mind are (AVXL, very popular on the boards and crazy volatile) & AXON. Both involved in Alzheimer's disease/neurodegenerative disorders.

Anywho, a couple of links regarding general cost and I'm sure their are tons more seeking alpha has some great articles, also.

https://aspe.hhs.gov/report/examination-clinical-trial-costs-and-barriers-drug-development

http://www.ca-biomed.org/pdf/media-kit/fact-sheets/CBRADrugDevelop.pdf

And still run the risk of failing in phase III trails...the failure, back in March was devastating...but there may still be some hope...the question is can they survive and not be diluted out of the market...JMO

P.S. searching for the diamond in the rough is a risky venture. :)